These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8709557)

  • 1. Experimental intraperitoneal administration of cisplatin-activated carbon for rat ovarian adenocarcinomas.
    Sugiyama T; Nishida T; Kumagai S; Ushijima K; Shinagawa A; Okina H; Tomioka Y; Kataoka A; Yakushiji M
    Kurume Med J; 1996; 43(1):33-9. PubMed ID: 8709557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
    Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
    Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of intraperitoneal chemotherapy for rat ovarian cancer using cisplatin-containing microspheres.
    Kumagai S; Sugiyama T; Nishida T; Ushijima K; Yakushiji M
    Jpn J Cancer Res; 1996 Apr; 87(4):412-7. PubMed ID: 8641974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a Hybrid System Containing an Alginic Acid-Based Nanogel and an
    Yamaguchi K; Hiraike O; Iwaki H; Matsumiya K; Nakamura N; Sone K; Ohta S; Osuga Y; Ito T
    Mol Pharm; 2021 Nov; 18(11):4090-4098. PubMed ID: 34662129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with cisplatin and schizophyllan for 7,12-dimethylbenz(a)anthracene-induced rat ovarian adenocarcinoma.
    Sugiyama T; Nishida T; Kumagai S; Imaishi K; Ushijima K; Kataoka A; Yakushiji M
    J Obstet Gynaecol (Tokyo 1995); 1995 Oct; 21(5):521-7. PubMed ID: 8542479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the intraperitoneal and intravenous routes of cisplatin administration in an advanced ovarian cancer model of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Am J Obstet Gynecol; 1985 Sep; 153(1):106-11. PubMed ID: 4041136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An experiment control study on the ovarian reserve function after cisplatin intraperitoneal or intravenous chemotherapy in rats model].
    Fan BZ; Xia H; Chu L; Tong XW
    Zhonghua Fu Chan Ke Za Zhi; 2017 Apr; 52(4):249-253. PubMed ID: 28441841
    [No Abstract]   [Full Text] [Related]  

  • 8. An experimental study of regional chemotherapy using CDDP-loaded microspheres for esophageal cancer.
    Nakamura Y; Hamabe Y; Ikuta H; Hyon SH; Kuroda Y
    Surg Today; 2002; 32(4):335-42. PubMed ID: 12027199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraperitoneal (Ip) high-dose cisplatinum (CDDP) chemotherapy in patients with advanced ovarian cancer].
    Noda T; Saitoh S; Ando Y; Nakanishi A; Maruya C; Yoh S; Hino K; Kiyozuka Y; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1985 May; 20(4):797-807. PubMed ID: 4056550
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm.
    Terauchi F; Moritake T; Yamamoto Y; Ogura H
    Int J Clin Oncol; 2002 Dec; 7(6):356-60. PubMed ID: 12494251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
    Nonaka M; Itamochi H; Kawaguchi W; Kudoh A; Sato S; Uegaki K; Naniwa J; Sato S; Shimada M; Oishi T; Terakawa N; Kigawa J; Harada T
    Int J Gynecol Cancer; 2012 Jul; 22(6):922-9. PubMed ID: 22672985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
    Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
    Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraperitoneal cisplatin chemotherapy for ovarian cancer].
    Hayashi H; Nishii H; Ueda K; Kunitou S; Wada S; Takanashi H; Kobayashi S; Yasuda M
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2043-8. PubMed ID: 11791382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal Delivery of Cisplatin via a Hyaluronan-Based Nanogel/in Situ Cross-Linkable Hydrogel Hybrid System for Peritoneal Dissemination of Gastric Cancer.
    Ohta S; Hiramoto S; Amano Y; Emoto S; Yamaguchi H; Ishigami H; Kitayama J; Ito T
    Mol Pharm; 2017 Sep; 14(9):3105-3113. PubMed ID: 28806513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].
    Sawada M; Ozaki M; Hongo J; Hirota Y; Inagaki M; Taniguchi H; Tateishi R; Mori Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):693-8. PubMed ID: 3548596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
    Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
    Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraperitoneal chemotherapy for ovarian adenocarcinoma: pharmacokinetics of cisplatin].
    Ravina JH; Szyller A; Mintz P; Ferrand S; Ciraru-Vigneron N; Zylberberg B; Bourdon R; Galliot M
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(2):193-7. PubMed ID: 1583298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of oxaliplatin versus cisplatin in intraperitoneal chemotherapy in cancers restricted to the peritoneal cavity in the rat.
    Los G; Mutsaers PH; Ruevekamp M; McVie JG
    Cancer Lett; 1990 May; 51(2):109-17. PubMed ID: 2344588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of intraperitoneal chemotherapy on retroperitoneal lymph node metastasis of ovarian cancer].
    Niu X; Peng Z; Ding S; Yang K
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Jun; 31(2):188-90. PubMed ID: 12515132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation of Chemoperfusion Treatment for Abdominal Carcinomatosis.
    Bespalov VG; Belyaeva OA; Kireeva GS; Senchik KY; Stukov AN; Belyaev AM
    Bull Exp Biol Med; 2015 May; 159(1):81-4. PubMed ID: 26033596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.